Anemia in patients with Covid-19: pathogenesis and clinical significance
Gaetano Bergamaschi,Federica Borrelli de Andreis,Nicola Aronico,Marco Vincenzo Lenti,Chiara Barteselli,Stefania Merli,Ivan Pellegrino,Luigi Coppola,Elisa Maria Cremonte,Gabriele Croce,Francesco Mordà,Francesco Lapia,Sara Ferrari,Alessia Ballesio,Alessandro Parodi,Francesca Calabretta,Maria Giovanna Ferrari,Federica Fumoso,Antonella Gentile,Federica Melazzini,Antonio Di Sabatino,Giampiera Bertolino,Silvia Codega,Filippo Costanzo,Roberto Cresci,Giuseppe Derosa,Michele Di Stefano,Francesco Falaschi,Carmine Iadarola,Elisabetta Lovati,Pietro Carlo Lucotti,Alessandra Martignoni,Caterina Mengoli,Emanuela Miceli,Amedeo Mugellini,Chiara Muggia,Patrizia Noris,Elisabetta Pagani,Ilaria Palumbo,Alessandro Pecci,Tiziano Perrone,Carla Pieresca,Paola Stefania Preti,Maria Concetta Russo,Carmelo Sgarlata,Luisa Siciliani,Andrea Staniscia,Francesca Torello Vjera,Giovanna Achilli,Andrea Agostinelli,Valentina Antoci,Francesco Banfi,Irene Benedetti,Michele Brattoli,Ginevra Cambiè,Roberta Canta,Sara Cococcia,Federico Conca,Mariangela Delliponti,Virginia Del Rio,Francesco Di Terlizzi,Anna Fiengo,Tommaso Forni,Giulia Freddi,Chiara Frigerio,Alessandra Fusco,Margherita Gabba,Matteo Garolfi,Giulia Gori,Giacomo Grandi,Paolo Grimaldi,Alice Lampugnani,Federica Lepore,Gianluca Lettieri,Jacopo Mambella,Chiara Mercanti,Alba Nardone,Luca Pace,Lucia Padovini,Lavinia Pitotti,Margherita Reduzzi,Giovanni Rigano,Giorgio Rotola,Umberto Sabatini,Lucia Salvi,Giovanni Santacroce,Jessica Savioli,Simone Soriano,Carmine Spataro,Debora Stefani,
DOI: https://doi.org/10.1007/s10238-020-00679-4
IF: 4.6
2021-01-08
Clinical and Experimental Medicine
Abstract:COVID-19 patients typically present with lower airway disease, although involvement of other organ systems is usually the rule. Hematological manifestations such as thrombocytopenia and reduced lymphocyte and eosinophil numbers are highly prevalent in COVID-19 and have prognostic significance. Few data, however, are available about the prevalence and significance of anemia in COVID-19. In an observational study, we investigated the prevalence, pathogenesis and clinical significance of anemia among 206 patients with COVID-19 at the time of their hospitalization in an Internal Medicine unit. The prevalence of anemia was 61% in COVID-19, compared with 45% in a control group of 71 patients with clinical and laboratory findings suggestive of COVID-19, but nasopharyngeal swab tests negative for SARS-CoV-2 RNA (<i>p</i> = 0.022). Mortality was higher in SARS-CoV-2 positive patients. In COVID-19, females had lower hemoglobin concentration than males and a higher prevalence of moderate/severe anemia (25% versus 13%, <i>p</i> = 0.032). In most cases, anemia was mild and due to inflammation, sometimes associated with iron and/or vitamin deficiencies. Determinants of hemoglobin concentration included: erythrocyte sedimentation rate, serum cholinesterase, ferritin and protein concentrations and number of chronic diseases affecting each patient. Hemoglobin concentration was not related to overall survival that was, on the contrary, influenced by red blood cell distribution width, age, lactate dehydrogenase and the ratio of arterial partial oxygen pressure to inspired oxygen fraction. In conclusion, our results highlight anemia as a common manifestation in COVID-19. Although anemia does not directly influence mortality, it usually affects elderly, frail patients and can negatively influence their quality of life.
medicine, research & experimental